Type 2 diabetic men often experience problems in their sex lives. However, a new study has offered hope for them.
In a recent placebo-controlled study, long acting testosterone undecanoate (an ester of testosterone) improved erectile function, intercourse satisfaction, and sexual desire scores in type 2 diabetic men with severe hypogonadism, a condition in which the body doesn’t produce enough testosterone.
Only sexual desire improved significantly with testosterone replacement therapy in those with mild hypogonadism. “The study’s results also suggest that trials of testosterone therapy should be for a minimum of six months and not shorter periods as suggested by some guidelines,” said lead author Dr. Geoffrey Hackett.
‘Long acting testosterone undecanoate improved erectile function, intercourse satisfaction, and sexual desire scores in type 2 diabetic men with severe hypogonadism.’
The study appears in the journal BJU International.